Day 1 :
Keynote Forum
Khaled Alkattan
Alfaisal University, Saudi Arabia
Keynote: Role of Surgery in NSCLC
Time : 10:00-10:45
Biography:
Khaled Manae Al-Kattan, Dean College of Medicine, Alfaisal university and Consultant Thoracic Surgery and lung transplant at King Faisal Specialist Hospital & Research Centre. He was a co-founder of both the Saudi thoracic society and Pan Arab Chest Society. He is the Middle East regent for the European Society of Thoracic Surgery. Have extensive research and publication in his field, presented many abstracts in international symposiums. Was invited as an international speaker in many medical events. He is the Chairman of the National Lung Cancer Study Group and the national lung transplant program.
Abstract:
Management of lung cancer remains a challenge; recent advances in medicine had little impact on the outcome of lung cancer. Although surgery remains the best treatment modality for early NSCLC, but are results satisfactory? While advanced NSCLC stage is more common, but can surgery play a role. The best surgical approach depends on do I have a diagnosis, Is the Staging accurate, especially T status (3&4) and with N (2&3), M (1a), Is surgical Treatment curative or improve survival, Is the patient fit for the procedure (Assessment). The best management process should consist on the following: Tumor board approach, Better diagnosis, staging, Better patient assessment, Better anesthesia, Better techniques (VATS, Instruments), Better results (Less Morbidity and Mortality) and More Aggressive (Better Adjuvant therapy). To Improve results we need Screening, Sensitive investigation tools, Better staging of tumors. The role of Lymphadenectomy, Postoperative follow up and
metastasectomy is to be determined. Also Surgical techniques (Sleeve and Enblock resections) , Adjuvant therapy should be now part of the outcome based results. All that will help to definition of poor prognostic factors and achieving better results.
Keynote Forum
Mohammed AlAhmari
Prince Sultan Military College of Health Sciences, Saudi Arabia
Keynote: Noninvasive ventilation (NIV) in Acute Respiratory Failure
Biography:
Mohammed AlAhmari is a consultant and Assistant Professor of Respiratory Care. He is the Vice Dean of Post-graduate Studies & Scientific Research; Chairman in Respiratory Care department and Institutional Research Board at Prince Sultan College of Health Sciences, Saudi Arabia. He completed his PhD in Respiratory Medicine, UCL, UK. He is a registered Respiratory Therapist (RRT); certified Tobacco Treatment Specialist (CTTS); and fellow of American Association for Respiratory Care (FAARC). In 2008, he was appointed as a Saudi Governor of Respiratory Care at International Council of Respiratory Care. He won research awards from ATS in 2011 and 2012 for his research on “The NIV in OSA and inflammation related to this therapy”. He has Chaired and lectured at many national and international scientific meetings. He serves as an Editorial Board Member in scientific journals.
Abstract:
Noninvasive ventilation (NIV) is the delivery of positive pressure ventilation to the upper airway without the need for invasive artificial airway. NIV has been extensively used in clinical practice in the last two decades. NIV is well recognized therapy in selected patients with acute respiratory failure (ARF) related to exacerbation of chronic obstructive pulmonary disease (COPD), acute cardiogenic pulmonary edema and immuno compromised patients. Several studies have also shown that noninvasive therapy plays a substantial role in reducing the need for endotracheal intubation, hospital stay, morbidity and mortality. Despite the presence of evidence supporting the use of NIV, there are still wide variations in the actual initiation, usage and NIV utilization throughout the world. This presentation will discuss the rationale to treat acute respiratory failure (ARF) with NIV, considering timing of initiation for such therapy. In early stage of un-established ARF, NIV may prevent invasive ventilation while in established ARF, if predictors of success met, this therapy may help to avoid the endotracheal intubation. Role of NIV in different sittings will be discussed with providing up-to date evidence based medicine. This presentation will demonstrate some data for utilization of NIV.